Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds Oct 20 • 6 min read Revive Therapeutics Ltd. announced it has signed an agreement with Havn Life Sciences Inc. to source naturally-derived psychedelic compounds for use in future investigational new drug.
Cybin and Clarmin Announce Closing of CDN$45 Million Oversubscribed Private Placement and Provide Update on RTO Oct 19 • 9 min read Cybin and Clarmin announced the closing of a private placement offering of an aggregate of 60M subscription receipts at a price of CDN$0.75 per subscription receipt for proceeds of CDN$45M.
MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing Oct 19 • 5 min read Mind Medicine (MindMed) Inc. announced that it has filed a preliminary short form prospectus with the securities commissions or similar authorities in each province of Canada, other than Québec.
Universal Ibogaine Retains Westmount Park Investments for Corporate Financial Advisory Services Oct 16 • 4 min read Universal Ibogaine Inc. announced it has entered a strategic agreement with Westmount Park Investments to receive financial advice on an ongoing basis.
Mind Cure Announces Geoff Belair as Chief Technology Officer Oct 15 • 7 min read Mind Cure Health Inc. announced the hiring of Geoff Belair as the company’s new Chief Technology Officer.